Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 958 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib Impurity 30 REF: 4Z-N-066047CAS: 66148-15-0	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 46 REF: 4Z-E-068059CAS: 1798807-39-2	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 21 REF: 4Z-N-066035CAS: 1912-30-7	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 39 REF: 4Z-O-032044CAS: 126702-17-8	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 28 REF: 4Z-E-068041CAS: 1187368-66-6	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 80 REF: 4Z-C-121085CAS: 868540-15-2	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 49 REF: 4Z-E-068062CAS: 888072-96-6	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 23 REF: 4Z-L-124028	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 48 REF: 4Z-L-124054	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 20 REF: 4Z-F-3128CAS: 875573-64-1	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 68 REF: 4Z-O-032073CAS: 503821-93-0	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 71 (Intedanib Impurity 71) REF: 4Z-N-066005CAS: 1987887-92-2	- - -	To inquire	Tue 10 Dec 24
7,7’-Nonane-1,9-diylbis[estra-1,3,5(10)-triene-3,17β-diol](Mixture of Diastereomers) REF: TR-N649350	- - -	322.00 €~2,073.00 €	Tue 10 Dec 24
N-Desmethyl Tamoxifen-d5 REF: TR-D293902CAS: 164365-16-6	- - -	351.00 €~2,410.00 €	Tue 10 Dec 24
Fulvestrant 9-Sulfone REF: TR-F862525CAS: 98008-06-1	- - -	328.00 €~2,221.00 €	Tue 10 Dec 24
Carfilzomib (2R,4S)-Diol REF: TR-C183470CAS: 1541172-75-1	- - -	177.00 €~1,293.00 €	Tue 10 Dec 24
Ethyl Ethanesulfonate REF: TR-E676565CAS: 1912-30-7	- - -	233.00 €~760.00 €	Tue 10 Dec 24
(E/Z)-4-Hydroxy Tamoxifen REF: TR-H954705CAS: 68392-35-8	- - -	89.00 €~201.00 €	Tue 10 Dec 24
N-Desmethyl-4-hydroxy Tamoxifen β-D-Glucuronide (E/Z Mixture) REF: TR-D292042CAS: 152764-52-8	- - -	315.00 €~2,073.00 €	Tue 10 Dec 24
(E)-4-Hydroxy Tamoxifen O-β-D-Glucuronide REF: TR-H954760CAS: 152764-51-7	>90%	317.00 €~2,036.00 €	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Nintedanib Impurity 30

Ref: 4Z-N-066047

Enzalutamide Impurity 46

Ref: 4Z-E-068059

Nintedanib Impurity 21

Ref: 4Z-N-066035

Olaparib Impurity 39

Ref: 4Z-O-032044

Enzalutamide Impurity 28

Ref: 4Z-E-068041

Carfilzomib Impurity 80

Ref: 4Z-C-121085

Enzalutamide Impurity 49

Ref: 4Z-E-068062

Lenvatinib Impurity 23

Ref: 4Z-L-124028

Lenvatinib Impurity 48

Ref: 4Z-L-124054

Fulvestrant Impurity 20

Ref: 4Z-F-3128

Olaparib Impurity 68

Ref: 4Z-O-032073

Nintedanib Impurity 71 (Intedanib Impurity 71)

Ref: 4Z-N-066005

7,7’-Nonane-1,9-diylbis[estra-1,3,5(10)-triene-3,17β-diol](Mixture of Diastereomers)

Ref: TR-N649350

N-Desmethyl Tamoxifen-d5

Ref: TR-D293902

Fulvestrant 9-Sulfone

Ref: TR-F862525

Carfilzomib (2R,4S)-Diol

Ref: TR-C183470

Ethyl Ethanesulfonate

Ref: TR-E676565

(E/Z)-4-Hydroxy Tamoxifen

Ref: TR-H954705

N-Desmethyl-4-hydroxy Tamoxifen β-D-Glucuronide (E/Z Mixture)

Ref: TR-D292042

(E)-4-Hydroxy Tamoxifen O-β-D-Glucuronide

Ref: TR-H954760